BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18259882)

  • 1. Chemoembolisation of rat colorectal liver metastases with drug eluting beads loaded with irinotecan or doxorubicin.
    Eyol E; Boleij A; Taylor RR; Lewis AL; Berger MR
    Clin Exp Metastasis; 2008; 25(3):273-82. PubMed ID: 18259882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic Arterial Infusion of Polyethylene Glycol Drug-eluting Beads for Primary and Metastatic Liver Cancer Therapy.
    Aliberti C; Carandina R; Sarti D; Mulazzani L; Catalano V; Felicioli A; Coschiera P; Fiorentini G
    Anticancer Res; 2016 Jul; 36(7):3515-21. PubMed ID: 27354617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transarterial chemoembolisation (TACE) using irinotecan-loaded beads for the treatment of unresectable metastases to the liver in patients with colorectal cancer: an interim report.
    Martin RC; Robbins K; Tomalty D; O'Hara R; Bosnjakovic P; Padr R; Rocek M; Slauf F; Scupchenko A; Tatum C
    World J Surg Oncol; 2009 Nov; 7():80. PubMed ID: 19886993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxorubicin and irinotecan drug-eluting beads for treatment of glioma: a pilot study in a rat model.
    Baltes S; Freund I; Lewis AL; Nolte I; Brinker T
    J Mater Sci Mater Med; 2010 Apr; 21(4):1393-402. PubMed ID: 20162337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical downstaging and neo-adjuvant therapy in metastatic colorectal carcinoma with irinotecan drug-eluting beads: a multi-institutional study.
    Bower M; Metzger T; Robbins K; Tomalty D; Válek V; Boudný J; Andrasina T; Tatum C; Martin RC
    HPB (Oxford); 2010 Feb; 12(1):31-6. PubMed ID: 20495642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete pathological response of unresectable liver metastases from colorectal cancer after trans-arterial chemoembolization with drug-eluting beads loaded with irinotecan (DEBIRI) and concomitant systemic FOLFOX: A case report from the FFCD 1201 trial.
    Pernot S; Artru P; Mithieux F; Marsot J; Watkin E; Pellerin O; Lledo G; Chalabreysse P; Desramé J; Taieb J
    Clin Res Hepatol Gastroenterol; 2015 Dec; 39(6):e73-7. PubMed ID: 26141343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoembolization with drug eluting beads preloaded with irinotecan (DEBIRI) vs doxorubicin (DEBDOX) as a second line treatment for liver metastases from cholangiocarcinoma: a preliminary study.
    Venturini M; Sallemi C; Agostini G; Marra P; Cereda S; Reni M; Aldrighetti L; De Cobelli F; Del Maschio A
    Br J Radiol; 2016 Nov; 89(1067):20160247. PubMed ID: 27558984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Toxicity of Hepatic Intra-Arterial Drug-Eluting (Irinotecan) Bead (DEBIRI) Therapy in Irinotecan-Refractory Unresectable Colorectal Liver Metastases.
    Bhutiani N; Akinwande O; Martin RC
    World J Surg; 2016 May; 40(5):1178-90. PubMed ID: 26711640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transarterial chemoembolization with irinotecan beads in the treatment of colorectal liver metastases: systematic review.
    Richardson AJ; Laurence JM; Lam VW
    J Vasc Interv Radiol; 2013 Aug; 24(8):1209-17. PubMed ID: 23885916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcatheter arterial chemoembolization (TACE) of colorectal cancer liver metastases by irinotecan-eluting microspheres in a salvage patient population.
    Huppert P; Wenzel T; Wietholtz H
    Cardiovasc Intervent Radiol; 2014 Feb; 37(1):154-64. PubMed ID: 23670568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective TACE with irinotecan-loaded 40 μm microspheres and FOLFIRI for colorectal liver metastases: phase I dose escalation pharmacokinetic study.
    Tanaka T; Sato T; Nishiofuku H; Masada T; Tatsumoto S; Marugami N; Otsuji T; Kanno M; Koyama F; Sho M; Kichikawa K
    BMC Cancer; 2019 Aug; 19(1):758. PubMed ID: 31370815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stability of irinotecan-loaded drug eluting beads (DC Bead) used for transarterial chemoembolization.
    Kaiser J; Thiesen J; Krämer I
    J Oncol Pharm Pract; 2010 Mar; 16(1):53-61. PubMed ID: 19617306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trans-Arterial Chemoembolization with Irinotecan-Loaded Drug-Eluting Beads (DEBIRI) and Capecitabine in Refractory Liver Prevalent Colorectal Metastases: A Phase II Single-Center Study.
    Iezzi R; Marsico VA; Guerra A; Cerchiaro E; Cassano A; Basso M; Devicienti E; Rodolfino E; Barone C; Bonomo L
    Cardiovasc Intervent Radiol; 2015 Dec; 38(6):1523-31. PubMed ID: 25799948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxorubicin and mitoxantrone drug eluting beads for the treatment of experimental peritoneal carcinomatosis in colorectal cancer.
    Keese M; Gasimova L; Schwenke K; Yagublu V; Shang E; Faissner R; Lewis A; Samel S; Löhr M
    Int J Cancer; 2009 Jun; 124(11):2701-8. PubMed ID: 19165866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoembolization of rat liver metastasis with irinotecan and quantification of tumor cell reduction.
    Saenger J; Leible M; Seelig MH; Berger MR
    J Cancer Res Clin Oncol; 2004 Apr; 130(4):203-10. PubMed ID: 14740207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PARAGON II - A single arm multicentre phase II study of neoadjuvant therapy using irinotecan bead in patients with resectable liver metastases from colorectal cancer.
    Jones RP; Malik HZ; Fenwick SW; Terlizzo M; O'Grady E; Stremitzer S; Gruenberger T; Rees M; Plant G; Figueras J; Albiol M; Adam R; Awad S; Poston GJ
    Eur J Surg Oncol; 2016 Dec; 42(12):1866-1872. PubMed ID: 27561844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transarterial chemoembolization with degradable starch microspheres, irinotecan, and mitomycin-C in patients with liver metastases.
    Morise Z; Sugioka A; Kato R; Fujita J; Hoshimoto S; Kato T
    J Gastrointest Surg; 2006 Feb; 10(2):249-58. PubMed ID: 16455458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting pharmacokinetic behaviour of drug release from drug-eluting embolization beads using in vitro elution methods.
    Hagan A; Caine M; Press C; Macfarlane WM; Phillips G; Lloyd AW; Czuczman P; Kilpatrick H; Bascal Z; Tang Y; Garcia P; Lewis AL
    Eur J Pharm Sci; 2019 Aug; 136():104943. PubMed ID: 31152772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of biocompatibility and anti-glioma efficacy of doxorubicin and irinotecan drug-eluting bead suspensions in alginate.
    Glage S; Lewis AL; Mertens P; Baltes S; Geigle P; Brinker T
    Clin Transl Oncol; 2012 Jan; 14(1):50-9. PubMed ID: 22262719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary artery chemoembolization in a sheep model: Evaluation of performance and safety of irinotecan eluting beads (DEB-IRI).
    Baylatry MT; Pelage JP; Wassef M; Ghegediban H; Joly AC; Lewis A; Lacombe P; Fernandez C; Laurent A
    J Biomed Mater Res B Appl Biomater; 2011 Aug; 98(2):351-9. PubMed ID: 21656666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.